<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://media.rss.com/style.xsl"?>
<rss xmlns:podcast="https://podcastindex.org/namespace/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:psc="http://podlove.org/simple-chapters" xmlns:atom="http://www.w3.org/2005/Atom" xml:lang="en" version="2.0">
  <channel>
    <title><![CDATA[Endocrine Feedback Loop]]></title>
    <link>https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series</link>
    <atom:link href="https://media.rss.com/endocrine-feedback-loop/feed.xml" rel="self" type="application/rss+xml"/>
    <atom:link rel="hub" href="https://pubsubhubbub.appspot.com/"/>
    <description><![CDATA[Endocrine Feedback Loop is a monthly journal club podcast series brought to you by the Endocrine Society. Hosted by endocrinologist Chase Hendrickson, MD, from Vanderbilt University, each episode features an expert educator and a topical specialist dissecting recently published journal articles and discussing implications for clinical practice.]]></description>
    <generator>RSS.com 2026.401.141116</generator>
    <lastBuildDate>Mon, 27 Apr 2026 17:11:15 GMT</lastBuildDate>
    <language>en</language>
    <copyright><![CDATA[Endocrine Society. Copyright 2026]]></copyright>
    <itunes:image href="https://media.rss.com/endocrine-feedback-loop/podcast_cover.jpg"/>
    <podcast:guid>0b340775-348e-581b-89ab-990e803103d8</podcast:guid>
    <image>
      <url>https://media.rss.com/endocrine-feedback-loop/podcast_cover.jpg</url>
      <title>Endocrine Feedback Loop</title>
      <link>https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series</link>
    </image>
    <podcast:locked>yes</podcast:locked>
    <podcast:license>Endocrine Society. Copyright 2026</podcast:license>
    <itunes:author>Endocrine Society</itunes:author>
    <itunes:owner>
      <itunes:name>Endocrine Society</itunes:name>
    </itunes:owner>
    <itunes:explicit>false</itunes:explicit>
    <itunes:type>episodic</itunes:type>
    <itunes:category text="Health &amp; Fitness">
      <itunes:category text="Medicine"/>
    </itunes:category>
    <podcast:medium>podcast</podcast:medium>
    <podcast:txt purpose="ai-content">false</podcast:txt>
    <item>
      <title><![CDATA[EFL072 - Pre-Operative Use of Mineralocorticoid-Receptor Antagonists in Primary Aldosteronism]]></title>
      <itunes:title><![CDATA[EFL072 - Pre-Operative Use of Mineralocorticoid-Receptor Antagonists in Primary Aldosteronism]]></itunes:title>
      <description><![CDATA[<p>For our 72nd episode and the final episode of the sixth season, we review a recent study examining the perioperative medical management of primary aldosteronism, with a focus on the use of mineralocorticoid receptor antagonists before adrenalectomy. Primary aldosteronism is increasingly recognized as a common and clinically important cause of secondary hypertension, yet questions remain about optimal preoperative treatment strategies. This study explores whether pretreatment with mineralocorticoid receptor antagonists influences postoperative outcomes and longer‑term biochemical cure in patients undergoing surgery.</p><p>Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt University, talks with regular contributor Salila Kurra, MD, from Columbia University, and guest expert Jun Yang, MD, PhD, from Monash Health in Melbourne, Australia. Together, they discuss <a target="_blank" rel="noopener noreferrer nofollow" href="https://doi.org/10.1210/clinem/dgaf545">"Mineralocorticoid Receptor Antagonist Pre-Adrenalectomy in Primary Aldosteronism,"</a> published in the April 2026 issue of JCEM, and consider how these findings may inform perioperative management and surgical decision-making in clinical practice.</p>]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2757671</link>
      <enclosure url="https://content.rss.com/episodes/383117/2757671/endocrine-feedback-loop/2026_04_22_13_41_07_df9aadc8-2d4e-44f0-bdb2-3910f949561d.mp3" length="42109645" type="audio/mpeg"/>
      <guid isPermaLink="false">838c2cab-388c-4659-8b5d-3e2c5ed0e418</guid>
      <itunes:duration>2628</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>6</itunes:season>
      <podcast:season>6</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 22 Apr 2026 13:41:34 GMT</pubDate>
      <podcast:txt purpose="ai-content">false</podcast:txt>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/ep_cover_20260422_020459_d50cb718411d2463eb860e8cda709e0a.png"/>
    </item>
    <item>
      <title><![CDATA[EFL071 – Taste Changes with Semaglutide]]></title>
      <itunes:title><![CDATA[EFL071 – Taste Changes with Semaglutide]]></itunes:title>
      <description><![CDATA[<p>For our 71st episode, we review a randomized, placebo-controlled clinical trial that explores how semaglutide may influence taste perception in women with obesity and polycystic ovary syndrome. While GLP‑1 receptor agonists are widely used for weight loss, the mechanisms underlying changes in food preference remain less well understood. This study takes a multimodal approach to examine whether semaglutide alters taste recognition, tongue gene expression, and brain responses to food-related cues. Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt University, talks with regular contributor Na Shen, MD, from UCLA, and guest expert Kalpana Muthusamy, M.B.B.S., MD, from Mayo Clinic in Rochester, Minnesota. Together, they discuss <a target="_blank" rel="noopener noreferrer nofollow" href="https://academic.oup.com/jcem/article-abstract/111/1/e270/8127627"><strong>"Semaglutide and Taste in Women With Obesity and Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Study,"</strong></a> published in the January 2026 issue of JCEM.</p>]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753225</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753225/endocrine-feedback-loop/2026_04_21_17_18_29_7924d55f-0d44-4358-b0a4-6c3c39809517.mp3" length="29710268" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/endosociety/Files/podcasts/EFL/EFL071_MP3.mp3</guid>
      <itunes:duration>1854</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>6</itunes:season>
      <podcast:season>6</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Fri, 27 Mar 2026 15:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_f7a8b407b92620dfdfe89837d4750f54.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL070 – Dosing Strategies for Remission in Graves Disease]]></title>
      <itunes:title><![CDATA[EFL070 – Dosing Strategies for Remission in Graves Disease]]></itunes:title>
      <description><![CDATA[<p>For our 70th episode, we review a paper that tries to improve our understanding of remission in Graves’ disease. Long-term thionamide treatment has long been the preferred approach internationally in Graves’ disease, and only more recently here in the U.S. So, the more we know about dosing and how that might encourage or predict remission, the better. This report is an observational study, as is often the case with the papers we look at, so we will discuss how these authors approach this question and share our thoughts along the way. Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt University, talks with regular contributor Andy Crawford, MD, from Dartmouth-Hitchcock Medical Center, and guest expert Giuseppe Barbesino, MD, from Harvard Medical School in Boston. They discuss<strong> </strong><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1210/clinem/dgaf433"><strong>"Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves' Disease"</strong></a> by Miyamura et al., published in the August 2025 issue of JCEM.</p>]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753224</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753224/endocrine-feedback-loop/2026_04_21_17_18_15_3e220e21-834f-4568-a752-ae71d46913be.mp3" length="33806210" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/endosociety/Files/podcasts/EFL/EFL070_MP3.mp3</guid>
      <itunes:duration>2112</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>6</itunes:season>
      <podcast:season>6</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 19 Feb 2026 09:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/ep_cover_20260422_020421_14dff50734427d6c9b1e623788effd59.png"/>
    </item>
    <item>
      <title><![CDATA[EFL069 - The Gut Microbiome in Type 1 Diabetes and Obesity]]></title>
      <itunes:title><![CDATA[EFL069 - The Gut Microbiome in Type 1 Diabetes and Obesity]]></itunes:title>
      <description><![CDATA[<p>For our 69th episode, we review a paper in <em>The Journal of Clinical Endocrinology &amp; Metabolism</em> on the gut microbiome of adolescents with type 1 diabetes, which hopes to understand differences between those with a normal body mass index compared to obesity. Studying gut microbiomes has been a “hot topic” for several years now, and we are excited to take the opportunity to unpack this work and see how it helps us better understand our patients. We both work through the challenges that come with any observational study and learn more about the specific techniques used by these investigators in this study. Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt University talks with regular contributor Ashok Balasubramanyam, MD, from Baylor College of Medicine, and guest expert Åke Lernmark, MD, PhD, professor emeritus from Lund University in Malmö, Sweden. They discuss <a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1210/clinem/dgae529"><strong>“Gut Microbial Changes Associated With Obesity in Youth With Type 1 Diabetes”</strong></a> by Ismail et al, published in the February 2025 issue of JCEM.</p>]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753223</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753223/endocrine-feedback-loop/2026_04_21_17_18_27_62ff6242-51d6-4ef6-ab38-ebf2b942f5a4.mp3" length="39530991" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/c5cb610069a040f5a746fde01c0fc8ae.mp3</guid>
      <itunes:duration>2460</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>6</itunes:season>
      <podcast:season>6</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 15 Jan 2026 09:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_f6434039d779dbfe9bb782e4483c2103.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL068 - Hypocalcemia in CKD after Denosumab]]></title>
      <itunes:title><![CDATA[EFL068 - Hypocalcemia in CKD after Denosumab]]></itunes:title>
      <description><![CDATA[<p>For our 68th episode, we look at a paper in <em>The Journal of Clinical Endocrinology &amp; Metabolism</em> that compares the effect on calcium of initial and subsequent doses of denosumab in people with chronic kidney disease (CKD). Though concerns have arisen over the years about the problems with stopping denosumab therapy, it remains an appealing medication for some of our patients with CKD. So we thought this report had the potential to change our practice and gave us the opportunity to delve into the challenges around osteoporosis in CKD. Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt University talks with regular contributor Amal Shibli-Rahhal, MD, from University of Iowa Carver College of Medicine, and guest expert Kristin Clemens, MD, from St. Joseph’s Hospital and Western University in London, Ontario, Canada. They discuss <a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1210/clinem/dgae721"><strong>“Dose-Specific Effects of Denosumab on Serum Calcium Levels in Patients With Osteoporosis and Various Renal Functions”</strong></a> by Sun et al, published in the July 2025 issue of JCEM.</p>]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753222</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753222/endocrine-feedback-loop/2026_04_21_17_17_36_b46be044-75d0-4b57-a991-f5618874bf07.mp3" length="34624634" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/53402c775471454db35bfd304dd13ba6.mp3</guid>
      <itunes:duration>2154</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>6</itunes:season>
      <podcast:season>6</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 18 Dec 2025 09:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_352dcec7a720d4ab3154ffa72f7684a4.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL067 - Bariatric Surgery and Changes in Body Composition and Musculoskeletal Health]]></title>
      <itunes:title><![CDATA[EFL067 - Bariatric Surgery and Changes in Body Composition and Musculoskeletal Health]]></itunes:title>
      <description><![CDATA[<p>For our 67th episode, we look at a study in <em>The Journal of Clinical Endocrinology &amp; Metabolism</em> that reports the impact of different types of weight-loss surgery on body composition, muscle strength, and bone density. Our patients frequently ask questions about these changes with surgical and medical weight loss, so we thought it highly worthwhile to review these findings with you all. Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt University talks with regular contributor Andrew Kraftson, MD, from the University of Michigan, and guest expert Anne Schafer, MD, from the University of California, San Francisco. They discuss <a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1210/clinem/dgae496"><strong>“One Year Changes in Body Composition and Musculoskeletal Health Following Metabolic/Bariatric Surgery”</strong></a> by Jassil et al, published in the May 2025 issue of JCEM.</p>]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753221</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753221/endocrine-feedback-loop/2026_04_21_17_18_25_46d25fbf-9425-4e05-b81b-2e3fb7d09bec.mp3" length="41464329" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/6e111725074841e8ba93d02585406cf7.mp3</guid>
      <itunes:duration>2581</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>6</itunes:season>
      <podcast:season>6</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 20 Nov 2025 15:15:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_271608cb820111a3c526e0b84ffaccc2.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL066 - Islet Autoantibodies]]></title>
      <itunes:title><![CDATA[EFL066 - Islet Autoantibodies]]></itunes:title>
      <description><![CDATA[<p>For our 66th episode, we review a recent <em>Journal of the Endocrine Society</em> (JES) article that looks at the frequency of positive islet antibodies in a population of adults without diabetes. While that may initially seem like an unusual article choice, we found it to be quite helpful in an era where we now have a therapeutic option to delay the onset of clinical type 1 diabetes when we can identify people early enough. That treatment option naturally raises questions about how we can find such patients and the risk of false-positive results with these antibodies. Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt University talks with regular contributor Steven D. Wittlin, MD, from the University of Rochester Medical Center, and guest expert Raghu G. Mirmira, MD, PhD, from the University of Chicago. They discuss <a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1210/jendso/bvaf095"><strong>“Prevalence of Islet Autoantibodies in Adults Without Diabetes”</strong></a> by Pauley et al, published in the August 2025 issue of JES.</p>]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753220</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753220/endocrine-feedback-loop/2026_04_21_17_18_07_19269f79-3313-475f-b7fc-c623cc95b65e.mp3" length="34399798" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/addb868745c949e9add56a11c77215c4.mp3</guid>
      <itunes:duration>2140</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>6</itunes:season>
      <podcast:season>6</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 16 Oct 2025 08:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_f9c7d3dc665fd531115350c7fda74f56.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL065 - MACS and Vertebral Fractures]]></title>
      <itunes:title><![CDATA[EFL065 - MACS and Vertebral Fractures]]></itunes:title>
      <description><![CDATA[<p>For our 65th episode, we return to <em>The Journal of Clinical Endocrinology &amp; Metabolism</em> to look at a report of two different studies that investigate the relationship between MACS (mild autonomous cortisol secretion) and vertebral fractures. MACS has been of increasing interest to endocrinologists over the past few years, with a greater recognition of its health impact and new guidelines on its assessment and treatment. As this topic continues to evolve, we thought that this paper has a high likelihood of impacting our clinical care and so is well worth discussion. Host Chase Hendrickson, MD, from Vanderbilt University talks with regular contributor Jill Wagoner, MD, from the University of Nebraska Medical Center, and guest expert Oksana Hamidi, DO, from the University of Texas Southwestern Medical Center. They discuss <a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1210/clinem/dgaf227"><strong>“Adrenalectomy Reduces the Risk of Vertebral Fractures in Patients With Mild Autonomous Cortisol Secretion”</strong></a> by Morelli et al, first published online in JCEM in April 2025.</p>]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753219</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753219/endocrine-feedback-loop/2026_04_21_17_18_28_718d48af-d624-4c05-8b69-72e510671321.mp3" length="41229909" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/5e43506b12a244f69f7530889b08766b.mp3</guid>
      <itunes:duration>2566</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>6</itunes:season>
      <podcast:season>6</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 18 Sep 2025 07:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_cc3b913caa0b06dc8e713e3422a89314.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL064 - Subclinical Thyroid Disease and Cardiovascular Risk Factors]]></title>
      <itunes:title><![CDATA[EFL064 - Subclinical Thyroid Disease and Cardiovascular Risk Factors]]></itunes:title>
      <description><![CDATA[<p>For our 64th episode, we return to <em>The Journal of Clinical Endocrinology &amp; Metabolism</em> to review a recent paper that attempts to elucidate the connection between subclinical thyroid disease and cardiovascular disease. Any of you listeners who see patients with thyroid conditions likely frequently encounter people with mild thyroid abnormalities and need to figure out if those abnormalities may have a clinical impact. So, given the many unanswered questions in this area, we thought this article well worth discussing. Not only do these authors use an observational study design, but their work is a pooling of multiple observational investigations, necessitating a careful thinking through of the methodology. Host Chase Hendrickson, MD, from Vanderbilt University talks with regular contributor Anupam Kotwal, MD, from the University of Nebraska Medical Center, and guest expert Jennifer S. Mammen, MD, PhD, from Johns Hopkins University School of Medicine. They discuss <a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1210/clinem/dgae860"><strong>“Associations Between Subclinical Thyroid Dysfunction and Cardiovascular Risk Factors According to Age and Sex”</strong></a> by Baretella et al, published in the May 2025 issue of JCEM.</p>]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753218</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753218/endocrine-feedback-loop/2026_04_21_17_18_02_bfe7a90f-8667-4ebd-94c6-3c95a249e926.mp3" length="47494409" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/e0d2d83330b74533b8e6d957fe347595.mp3</guid>
      <itunes:duration>2957</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>6</itunes:season>
      <podcast:season>6</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 21 Aug 2025 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_3f205c8bccf3ecb2f23585370d8b04de.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL063 - Diagnosing Adrenal Insufficiency]]></title>
      <itunes:title><![CDATA[EFL063 - Diagnosing Adrenal Insufficiency]]></itunes:title>
      <description><![CDATA[<p>For our 63rd episode, we returned to the Endocrine Society’s annual meeting and recorded before a live audience at ENDO 2025 in San Francisco. We look at a study from <em>The Journal of Clinical Endocrinology &amp; Metabolism</em> that suggests that we can substantially alter our diagnostic approach to adrenal insufficiency. This study and others have already led to a shift in recommendations from some experts, so we thought it would be of great interest to you all as our listeners. Host Chase Hendrickson, MD, from Vanderbilt University talks with regular contributor Katie Guttenberg, MD, from the University of Texas Health Science Center at Houston, and guest expert Anand Vaidya, MD, from Brigham and Women’s Hospital and Harvard Medical School in Boston.</p><p>They discuss <a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1210/clinem/dgae855"><strong>“Performance of Dehydroepiandrosterone Sulfate and Baseline Cortisol in Assessing Adrenal Insufficiency”</strong></a> by Han et al, first published online in JCEM in December 2024.</p>]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753217</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753217/endocrine-feedback-loop/2026_04_21_17_17_12_180579cd-5156-4504-8d79-db71aecb68aa.mp3" length="41924048" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/9e4e5298e07a447991bc86988b4d07f0.mp3</guid>
      <itunes:duration>2609</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>6</itunes:season>
      <podcast:season>6</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 24 Jul 2025 10:40:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_0a6eabcdbefda770495932c150bc3d5b.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL062 - Primary Hyperparathyroidism in Pregnancy]]></title>
      <itunes:title><![CDATA[EFL062 - Primary Hyperparathyroidism in Pregnancy]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recently published article in The Journal of Clinical Endocrinology & Metabolism that investigates the impact of primary hyperparathyroidism on fertility and pregnancy outcomes. Those who take care of primary hyperparathyroidism will have encountered the challenge of managing it around pregnancy and will be familiar with how little data we have to guide us there. The authors utilize an observational methodology, so we will do our usual, careful walk through the study design to highlight those intrinsic limitations. Dr. Hendrickson talks with Alyson K. Myers, MD, from the Albert Einstein College of Medicine, and guest expert Shonni J. Silverberg, MD, from Columbia University. The article featured this month, by Sant et al, was published in the May 2025 issue of JCEM: “Fertility and Pregnancy Outcomes in Primary Hyperparathyroidism: Observations From a Large Insured Population.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl062 — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753216</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753216/endocrine-feedback-loop/2026_04_21_17_18_29_27472075-011f-48a8-a742-df8281c3cf07.mp3" length="46447451" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/489dc92e51384a319cf5bb3761284401.mp3</guid>
      <itunes:duration>2892</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>6</itunes:season>
      <podcast:season>6</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 26 Jun 2025 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_9f186912b0aebcd60e0fd4e816bbbfae.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL061 - Effectiveness of Lifestyle Intervention in Preventing T2D Based on Genetic Risk]]></title>
      <itunes:title><![CDATA[EFL061 - Effectiveness of Lifestyle Intervention in Preventing T2D Based on Genetic Risk]]></itunes:title>
      <description><![CDATA[Welcome to our 61st episode and the beginning of our sixth season! Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recently published clinical trial in The Journal of Clinical Endocrinology & Metabolism that tries to understand the impact of genetics on the benefits of a lifestyle program in reducing the risk of developing type 2 diabetes. Personalized or precision medicine has been a hot topic for several years now, and this podcast has recently reviewed a few studies that fit that description. The authors of this investigation try to answer the question of how we can decide in advance which patients are particularly likely to benefit from a given intervention. Dr. Hendrickson talks with Ashok Balasubramanyam, MD, from Baylor College of Medicine, and guest expert Miriam Udler, MD, PhD, from Massachusetts General Hospital. The article featured this month, by Lankinen et al, was published in the January 2025 issue of JCEM: “Effects of Genetic Risk on Incident Type 2 Diabetes and Glycemia: The T2D-GENE Lifestyle Intervention Trial.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl061 — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753215</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753215/endocrine-feedback-loop/2026_04_21_17_18_18_7cd98bd0-38e5-4445-83f0-48569e35cf72.mp3" length="41302064" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/355f615aa5f940329e819606718f43d2.mp3</guid>
      <itunes:duration>2571</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>6</itunes:season>
      <podcast:season>6</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 22 May 2025 11:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_00adda4601d0c6b9b4d2285fe77f3568.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL060 - Topiramate and Metformin for Weight Loss in PCOS]]></title>
      <itunes:title><![CDATA[EFL060 - Topiramate and Metformin for Weight Loss in PCOS]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent study in The Journal of Clinical Endocrinology & Metabolism that reports on the benefits of older weight-loss medications in a population of women with polycystic ovary syndrome (PCOS). Much of the attention today in obesity medicine focuses on GLP-1 receptor agonists. However, these medications are not treatment options for many of our patients, so we thought this paper asked important questions that we would want to know the answers to. Dr. Hendrickson talks with Na Shen, MD, from the University of California, Los Angeles, and guest expert Stanley G. Korenman, MD, also from UCLA. The article featured this month, by Bandeira Marchesan et al, was first published in JCEM in September 2024: “Topiramate Added to Metformin for Obesity Control in Women With Polycystic Ovary Syndrome.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl060 — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753213</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753213/endocrine-feedback-loop/2026_04_21_17_17_47_a56b8311-23ed-47f5-a36b-5f7a6822244e.mp3" length="33292404" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/9f209e9aedeb4be48941e9e33835907a.mp3</guid>
      <itunes:duration>2070</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>5</itunes:season>
      <podcast:season>5</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 01 May 2025 15:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_3f003147cc6d3364bb37bce9c105cb9c.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL059 - Testosterone Levels and Fracture Risk in Men]]></title>
      <itunes:title><![CDATA[EFL059 - Testosterone Levels and Fracture Risk in Men]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent investigation in The Journal of Clinical Endocrinology & Metabolism that tries to illuminate the relationship between serum testosterone and fractures in men. Ever since the release of the TRAVERSE fracture findings last year, we as endocrinologists have been uncertain in how to think about testosterone and bone health, as that trial made us question what we thought we already knew. So we thought that this article would be an important one to review and are eager to discuss it. Dr. Hendrickson talks with Anna Goldman, MD, from Harvard Medical School and guest expert Peter J. Snyder, MD, from the University of Pennsylvania. The article featured this month, by Grahnemo et al, was first published in JCEM in October 2024: “Associations of Serum Testosterone and SHBG With Incident Fractures in Middle-Aged to Older Men.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl059-testosterone-levels-and-fracture-risk-in-men — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753212</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753212/endocrine-feedback-loop/2026_04_21_17_17_54_645b8c61-18f2-4963-bb5a-a75292ccb55d.mp3" length="32997479" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/bcb9caef17054e1cb117a89ff5709e63.mp3</guid>
      <itunes:duration>2052</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>5</itunes:season>
      <podcast:season>5</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 20 Mar 2025 12:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_dace927af96e654495a2b711f682b206.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL058 - BMI vs Percent Body Fat in Defining Obesity]]></title>
      <itunes:title><![CDATA[EFL058 - BMI vs Percent Body Fat in Defining Obesity]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a study in The Journal of Clinical Endocrinology & Metabolism that reports the relationship between body mass index and percent body fat in terms of defining overweight and obesity. He talks with Andrew Kraftson, MD, from the University of Michigan and guest expert Beverly Tchang, MD, from Weill Cornell Medicine in New York City. The article featured this month, by Potter et al, was first published in JCEM in May 2024: “Defining Overweight and Obesity by Percent Body Fat Instead of Body Mass Index.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl058-bmi-vs-percent-body-fat-in-defining-obesity — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753211</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753211/endocrine-feedback-loop/2026_04_21_17_17_40_1453980d-8a25-43bf-9ff6-e469368ddde5.mp3" length="42231733" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/7f7605a562d04cc78128e7bbf22f1dd7.mp3</guid>
      <itunes:duration>2629</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>5</itunes:season>
      <podcast:season>5</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 20 Feb 2025 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_d299833a646e94d75f05186a16abc18e.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL057 - Weaning Glucocorticoids and HPA Recovery]]></title>
      <itunes:title><![CDATA[EFL057 - Weaning Glucocorticoids and HPA Recovery]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a study in The Journal of Clinical Endocrinology & Metabolism that gives insight into how we should wean patients off long-term glucocorticoid use and how successful that typically is. He talks with Salila Kurra, MD, from Columbia University and guest expert Felix Beuschlein, MD, from University Clinic Zurich in Switzerland. The article featured this month, by Arshad et al, was published in the November 2024 issue of JCEM: “A Retrospective Study on Weaning Glucocorticoids and Recovery of the Hypothalamic-Pituitary-Adrenal Axis.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl057-weaning-glucocorticoids-and-hpa-recovery — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753210</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753210/endocrine-feedback-loop/2026_04_21_17_16_54_4b719def-2678-4ee3-88d5-b4b3f18ac4e7.mp3" length="33022820" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/d6a6e557f0914c54ac1e2671e76db222.mp3</guid>
      <itunes:duration>2054</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>5</itunes:season>
      <podcast:season>5</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 16 Jan 2025 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_4fc9328405087190d38ff189fd34a748.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL056 - Renin Measurements in Primary Adrenal Insufficiency]]></title>
      <itunes:title><![CDATA[EFL056 - Renin Measurements in Primary Adrenal Insufficiency]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in Journal of the Endocrine Society assessing plasma renin in the management of individuals with primary adrenal insufficiency. He talks with Jill Wagoner, MD, from the University of Nebraska and guest expert Irina Bancos, MD, from Mayo Clinic. The article featured this month, by Piazzola et al, was published in the November 2024 issue of JES: “Plasma Renin: A Useful Marker for Mineralocorticoid Adjustment in Patients With Primary Adrenal Insufficiency.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl056-renin-measurements-in-primary-adrenal-insufficiency — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753209</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753209/endocrine-feedback-loop/2026_04_21_17_17_31_ba7f8576-ae96-4bd4-8731-47f5b56fcfd6.mp3" length="34090084" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/13b772666aeb42d0a05098de2edfff27.mp3</guid>
      <itunes:duration>2120</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>5</itunes:season>
      <podcast:season>5</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 19 Dec 2024 05:08:30 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_f840538c6cbb48f6125ee1cea7443c7e.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL055 - T3 Replacement in the Treatment of Hypothyroidism]]></title>
      <itunes:title><![CDATA[EFL055 - T3 Replacement in the Treatment of Hypothyroidism]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent systematic review and meta-analysis in The Journal of Clinical Endocrinology & Metabolism about the role for T3 replacement in the treatment of people with hypothyroidism. He talks with Andrew Crawford, MD, from Dartmouth-Hitchcock Medical Center and guest expert James Hennessey, MD, from Beth Israel Deaconess Medical Center. The article featured this month, by Esberard de Lima Beltrão et al, was first published online in JCEM in September 2024: “Treatment Preferences in Patients With Hypothyroidism.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl055-t3-replacement-in-the-treatment-of-hypothyroidism — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753208</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753208/endocrine-feedback-loop/2026_04_21_17_17_43_57ccd376-de6a-41a5-a382-978e5a59d404.mp3" length="37901796" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/91169b62675b4b1d99aeb376b898910c.mp3</guid>
      <itunes:duration>2358</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>5</itunes:season>
      <podcast:season>5</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 21 Nov 2024 17:30:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_a0337b1f6a31716d835f88aa18f3c502.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL054 - Renal Protection of Metformin]]></title>
      <itunes:title><![CDATA[EFL054 - Renal Protection of Metformin]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism providing data in support of metformin being renal protective. He talks with Steven D. Wittlin, MD, from the University of Rochester Medical Center and guest expert Silvio Inzucchi, MD, medical director of the Yale Medicine Diabetes Center. The article featured this month, by Wang et al, was first published online in JCEM in July 2024: “Renal Protective Effect of Metformin in Type 2 Diabetes Patients.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl054-renal-protection-of-metformin — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753207</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753207/endocrine-feedback-loop/2026_04_21_17_16_46_d4ed3aff-aead-41b2-9f60-34b007408430.mp3" length="45121250" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/b0f7e6de73be4278923c7539e06b5eb4.mp3</guid>
      <itunes:duration>2809</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>5</itunes:season>
      <podcast:season>5</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 31 Oct 2024 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_ea4e34121054fd79dccdb9c40a42c818.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL053 - The Cost Effectiveness of Molecular Testing for Indeterminate Thyroid Nodules]]></title>
      <itunes:title><![CDATA[EFL053 - The Cost Effectiveness of Molecular Testing for Indeterminate Thyroid Nodules]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism about the impact of molecular testing for indeterminate thyroid nodules. He talks with Anupam Kotwal, MD, from the University of Nebraska Medical Center, and guest expert Sarah Mayson, MD, from the University of Colorado School of Medicine. The article featured this month, by Lévesque et al, was first published online in May 2024: “Publicly Funded Molecular Testing of Indeterminate Thyroid Nodules: Canada’s Experience.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl053-the-cost-effectiveness-of-molecular-testing-for-indeterminate-thyroid-nodules — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753205</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753205/endocrine-feedback-loop/2026_04_21_17_17_17_b9ab41f4-7d63-4863-b797-6d77b08b4ecf.mp3" length="39505646" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/94f26d3a55b945c482cfec6ad8755fd8.mp3</guid>
      <itunes:duration>2458</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>5</itunes:season>
      <podcast:season>5</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 19 Sep 2024 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_a695297157b6043a8abc1e5a22af4c8c.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL052 - Osteopenia as a Surgical Indication in Primary Hyperparathyroidism]]></title>
      <itunes:title><![CDATA[EFL052 - Osteopenia as a Surgical Indication in Primary Hyperparathyroidism]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism about the benefits of surgical cure of primary hyperparathyroidism in women with osteopenia. He talks with Alyson Myers, MD, from Albert Einsten College of Medicine, and guest expert Natalie Cusano, MD, from the Zucker School of Medicine at Hofstra University and the Lenox Hill Hospital in New York. The article featured this month, by Frey et al, was published in the June 2024 issue of JCEM: “Parathyroidectomy Improves Bone Density in Women With Primary Hyperparathyroidism and Preoperative Osteopenia.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl052-osteopenia-as-a-surgical-indication-in-primary-hyperparathyroidism — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753204</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753204/endocrine-feedback-loop/2026_04_21_17_16_36_1bff51d7-cd75-4557-9a6f-8f98edc41d18.mp3" length="36682760" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/325bf267e6d047d2bf64a75f0047c335.mp3</guid>
      <itunes:duration>2282</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>5</itunes:season>
      <podcast:season>5</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 22 Aug 2024 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_6865918bbd25740c97f20599d8f1a698.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL051 - PCOS Subtypes Redux]]></title>
      <itunes:title><![CDATA[EFL051 - PCOS Subtypes Redux]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism about polycystic ovarian syndrome. He talks with Anna Goldman, MD, from Harvard Medical School, and guest expert David Ehrmann, MD, from the University of Chicago. The article featured this month, by van der Ham et al, was first published online in JCEM in May 2024: “Clustering Identifies Subtypes With Different Phenotypic Characteristics in Women With Polycystic Ovary Syndrome.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl051-pcos-subtypes-redux — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753203</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753203/endocrine-feedback-loop/2026_04_21_17_16_30_aac53d39-d0ff-4bdd-80e9-94432ac38ef9.mp3" length="32294656" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/cf05a738c34049759ed7d0be2fc25559.mp3</guid>
      <itunes:duration>2008</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>5</itunes:season>
      <podcast:season>5</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 18 Jul 2024 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_7f255efa96d60a1f66fa74d4f6afa703.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL050 - Bisphosphonates and Atypical Femoral Fractures]]></title>
      <itunes:title><![CDATA[EFL050 - Bisphosphonates and Atypical Femoral Fractures]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion recorded in front of an audience at ENDO 2024 in Boston. He talks about a recent article in The Journal of Clinical Endocrinology & Metabolism with Amal Shibli-Rahhal, MD, from University of Iowa Carver College of Medicine, and guest expert Ghada El-Hajj Fuleihan, MD, from the American University of Beirut, along with four fellows who submitted questions ahead of time. The article featured this month, by Bauer et al, was first published online in JCEM in January 2024: “Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case-Cohort Study With Blinded Radiographic Review.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl050-bisphosphonates-and-atypical-femoral-fractures — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753202</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753202/endocrine-feedback-loop/2026_04_21_17_16_43_4aa8a8de-f41b-40fd-a5ad-66dcf2af3ede.mp3" length="44707752" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/bda0409ffd7449c4bd8d84368266a29b.mp3</guid>
      <itunes:duration>2783</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>5</itunes:season>
      <podcast:season>5</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 20 Jun 2024 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_581141634368595e648a0cfacf575b12.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL049 - Artificial Intelligence in the Diagnosis of Cushing Syndrome]]></title>
      <itunes:title><![CDATA[EFL049 - Artificial Intelligence in the Diagnosis of Cushing Syndrome]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, as we begin our fifth season of the podcast with a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism with Katie Guttenberg, MD, from UTHealth Houston, and guest expert Odelia B. Cooper, MD, from Cedars-Sinai Medical Center. The article featured this month, by Demir et al, was first published online in JCEM in March 2024: “Machine Learning May Be an Alternative to BIPSS in the Differential Diagnosis of ACTH-dependent Cushing Syndrome.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl049-artificial-intelligence-in-the-diagnosis-of-cushing-syndrome — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series. Announcement: If you will be at ENDO 2024 in Boston, come to a live recording of the podcast at 10 a.m. on Saturday, June 1, in the ENDO Expo Theater.]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753201</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753201/endocrine-feedback-loop/2026_04_21_17_18_06_2ef62596-ff66-4f01-a4a0-130f24789e2c.mp3" length="44360104" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/6e45882b810c45108457590808e51cbe.mp3</guid>
      <itunes:duration>2762</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>5</itunes:season>
      <podcast:season>5</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 16 May 2024 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_8e806be9567dc9738cae1c25478eaf87.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL048 - Active Surveillance for Larger Malignant Thyroid Nodules]]></title>
      <itunes:title><![CDATA[EFL048 - Active Surveillance for Larger Malignant Thyroid Nodules]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism with Anupam Kotwal, MD, from the University of Nebraska, and guest expert Megan Haymart, MD, from the University of Michigan. The article featured this month, by Altshuler et al, was first published online in JCEM in February 2024: “Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl048-active-surveillance-for-larger-malignant-thyroid-nodules — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753200</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753200/endocrine-feedback-loop/2026_04_21_17_17_13_2ebc56a8-8020-40bf-81d7-20799ea93944.mp3" length="36984843" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/60fedd5b2c3b4b4f8e04c6b52334b9a1.mp3</guid>
      <itunes:duration>2301</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>4</itunes:season>
      <podcast:season>4</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 25 Apr 2024 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_1dee1153359e08167fa9802dae0cefd8.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL047 - The Benefits of Tirzepatide in Hispanic/Latino Individuals]]></title>
      <itunes:title><![CDATA[EFL047 - The Benefits of Tirzepatide in Hispanic/Latino Individuals]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism with Alyson K. Myers, MD, from Albert Einstein College of Medicine and guest expert Leonor Corsino, MD, from Duke University School of Medicine. The article featured this month, by Frías et al, was published in the February 2024 issue of JCEM: “Tirzepatide in Hispanic/Latino Patients With Type 2 Diabetes: A Subgroup Analysis of the SURPASS Program.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl047-the-benefits-of-tirzepatide-in-hispanic-latino-individuals — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753199</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753199/endocrine-feedback-loop/2026_04_21_17_17_24_9ef67a4b-f256-40d1-95b8-63b145bfa1e1.mp3" length="38277711" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/1e7f221df7d04c5c8482287ee118f221.mp3</guid>
      <itunes:duration>2382</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>4</itunes:season>
      <podcast:season>4</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 21 Mar 2024 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_03d8d5302a98c3d37c456430c4f967cd.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL046 - Weight-Loss Surgery in Individuals With Type 2 Diabetes]]></title>
      <itunes:title><![CDATA[EFL046 - Weight-Loss Surgery in Individuals With Type 2 Diabetes]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism with Na Shen, MD, from the University of California, Los Angeles, and guest expert Ken Fujioka, MD, from the Scripps Clinic in San Diego. The article featured this month, by Osorio-Conles et al, was published in the November 2023 issue of JCEM: “Limited Bariatric Surgery-induced Weight Loss in Subjects With Type 2 Diabetes: Predictor Variables in Adipose Tissue.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753198</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753198/endocrine-feedback-loop/2026_04_21_17_16_29_69d063b1-72ae-4065-aebf-25569177654d.mp3" length="38020285" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/4af72a666a1c4207ab56fbdc3cb9d1ab.mp3</guid>
      <itunes:duration>2366</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>4</itunes:season>
      <podcast:season>4</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 15 Feb 2024 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_859b4849dfe0d512ad6ba0be227e7941.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL045 - Long-Term Effects of Anti-Obesity Medications]]></title>
      <itunes:title><![CDATA[EFL045 - Long-Term Effects of Anti-Obesity Medications]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism with Andrew Kraftson, MD, from the University of Michigan and guest expert Jaime Almandoz, MD, from the University of Texas Southwestern Medical Center in Dallas. The article featured this month, by Weintraub et al, was published in the September 2023 issue of JCEM: “Five-year Weight Loss Maintenance With Obesity Pharmacotherapy.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753196</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753196/endocrine-feedback-loop/2026_04_21_17_17_19_25e6de99-d9af-495c-9afe-240417a754d8.mp3" length="49957398" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/4c2c2da5b3a042138395ed9f74ac68c7.mp3</guid>
      <itunes:duration>3111</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>4</itunes:season>
      <podcast:season>4</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 18 Jan 2024 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_cb91730a590b3cd0f7181df8e9ceee94.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL044 - Long-Term Medical Treatment of Graves Disease]]></title>
      <itunes:title><![CDATA[EFL044 - Long-Term Medical Treatment of Graves Disease]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism with Jill Wagoner, MD, from the University of Colorado and guest expert David S. Cooper, MD, from Johns Hopkins University. The article featured this month, by Stokland et al, was first published online in JCEM in September 2023: “Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753195</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753195/endocrine-feedback-loop/2026_04_21_17_16_08_f7d12f0c-da70-4044-83e2-14363b9fd7d8.mp3" length="44552055" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/dc5d16970ca04102bab82f404e21c87e.mp3</guid>
      <itunes:duration>2774</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>4</itunes:season>
      <podcast:season>4</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 21 Dec 2023 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_af36e138c6902ec757d5e7fc6ee3d9e7.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL043 - The Impact of Surgical Delay in Thyroid Cancer]]></title>
      <itunes:title><![CDATA[EFL043 - The Impact of Surgical Delay in Thyroid Cancer]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism with Andrew Crawford, MD, from Dartmouth Geisel School of Medicine and guest expert Lindsay Bischoff, MD, a colleague from Vanderbilt. The article featured this month, by Chaves et al, was published in the October 2023 issue of JCEM: “Delay in Surgery and Papillary Thyroid Cancer Survival in the United States: A SEER-Medicare Analysis.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753194</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753194/endocrine-feedback-loop/2026_04_21_17_17_06_afb00a7a-4129-4a76-91ef-cdd2cf521974.mp3" length="36631187" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/5494eac6d4e543d4a10fdc54b72d7114.mp3</guid>
      <itunes:duration>2279</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>4</itunes:season>
      <podcast:season>4</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 16 Nov 2023 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_40b4b2fcd5eccc991728a1192f692181.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL042 - Synergistic Effects of GLP-1 RAs and Exercise]]></title>
      <itunes:title><![CDATA[EFL042 - Synergistic Effects of GLP-1 RAs and Exercise]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism with Steven D. Wittlin, MD, from the University of Rochester Medical Center and guest expert Zhenqi Liu, MD, from the University of Virginia. The article featured this month, by Ingersen et al, was first published online in JCEM in June: “Effects of Aerobic Training and Semaglutide Treatment on Pancreatic β-Cell Secretory Function in Patients With Type 2 Diabete.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753193</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753193/endocrine-feedback-loop/2026_04_21_17_16_51_a83c57c3-0f99-4a1b-9482-d421c8bde286.mp3" length="42966337" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/0b1eb0554c3b412bb35082d1da4d6591.mp3</guid>
      <itunes:duration>2675</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>4</itunes:season>
      <podcast:season>4</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 19 Oct 2023 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_fbe7a0220ef947ac25064fdee1387121.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL041 - Improving the Accuracy of the FRAX]]></title>
      <itunes:title><![CDATA[EFL041 - Improving the Accuracy of the FRAX]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism with Amal Shibli-Rahhal, MD, from the University of Iowa and guest expert Jad Sfeir, MD, from the Mayo Clinic. The article featured this month, by Jaiswal et al, was first published online in JCEM in July: “Hemoglobin Levels Improve Fracture Risk Prediction in Addition to FRAX Clinical Risk Factors and Bone Mineral Density.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753192</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753192/endocrine-feedback-loop/2026_04_21_17_17_05_2b53ed78-4eee-457f-b93e-ad7c45cb2649.mp3" length="42734144" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/c72eadfe2bd04c3cadb614606c2d8522.mp3</guid>
      <itunes:duration>2660</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>4</itunes:season>
      <podcast:season>4</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 05 Oct 2023 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_e7d743a886cd81827a0c8613ecc43944.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL040 - Increased Morbidity With Gynecomastia]]></title>
      <itunes:title><![CDATA[EFL040 - Increased Morbidity With Gynecomastia]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism with Anna L. Goldman, MD, from Harvard University and Brigham and Women’s Hospital and guest expert Glenn D. Braunstein, MD, from Cedars-Sinai and University of California, Los Angeles. The article featured this month, by Uldbjerg et al, can be found in the July 2023 issue of JCEM: “Increased Morbidity in Males Diagnosed With Gynecomastia: A Nationwide Register-based Cohort Study.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753191</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753191/endocrine-feedback-loop/2026_04_21_17_16_08_49621f84-c83b-4378-8646-04d950285201.mp3" length="41489926" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/08e764231ee94a1ab639aecf9f18f260.mp3</guid>
      <itunes:duration>2582</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>4</itunes:season>
      <podcast:season>4</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 24 Aug 2023 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_6e9975662368654a234d660d2310727e.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL039 - Changes in Pancreas Size and Shape in Type 1 Diabetes]]></title>
      <itunes:title><![CDATA[EFL039 - Changes in Pancreas Size and Shape in Type 1 Diabetes]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism with Ashok Balasubramanyam, MD, from Baylor College of Medicine and guest expert Taylor Triolo, MD, from University of Colorado. The article featured this month, by Wright et al, was first published online in JCEM in March 2023: “Longitudinal MRI Shows Progressive Decline in Pancreas Size and Altered Pancreas Shape in Type 1 Diabetes.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753189</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753189/endocrine-feedback-loop/2026_04_21_17_16_01_2575d8a9-aacf-4710-b47e-c5fbf3865cff.mp3" length="38240601" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/15537bde738e4cf68467e6da46e2b4b3.mp3</guid>
      <itunes:duration>2379</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>4</itunes:season>
      <podcast:season>4</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 20 Jul 2023 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_449a92d1f2dca3a6c97c9efe14266199.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL038 - Aldosterone-to-Renin Ratio Variability in Primary Aldosteronism]]></title>
      <itunes:title><![CDATA[EFL038 - Aldosterone-to-Renin Ratio Variability in Primary Aldosteronism]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion recorded live at ENDO 2023. He looks at a recent article in The Journal of Clinical Endocrinology & Metabolism with Salila Kurra, MD, from Columbia University, and guest expert William Young Jr., MD, from Mayo Clinic College of Medicine, along with four fellows who submitted questions ahead of time. The article featured this month, by Ng et al, was published in the January 2023 issue of JCEM: “Aldosterone, Renin, and Aldosterone-to-Renin Ratio Variability in Screening for Primary Aldosteronism.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753188</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753188/endocrine-feedback-loop/2026_04_21_17_16_27_9ac9baf3-2fc4-4891-8f34-3516179c805f.mp3" length="37407282" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/2a94396c8d9d4022afa5fc70ef255c45.mp3</guid>
      <itunes:duration>2327</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>4</itunes:season>
      <podcast:season>4</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 22 Jun 2023 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_9b16ca63d0f614bb311fe51fd42adc5b.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL037 - Predicting HPA Function After Pituitary Surgery]]></title>
      <itunes:title><![CDATA[EFL037 - Predicting HPA Function After Pituitary Surgery]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, as he discusses a recent article in Journal of the Endocrine Society with Katie Guttenberg, MD, from University of Texas Health Science Center at Houston, and guest expert Diane Donegan, MD, from Indiana School of Medicine. The article featured this month, by Asuzu et al, was published in the April 2023 issue of JES: “Cortisol and ACTH Measurements at Extubation From Pituitary Surgery Predicts Hypothalamic-Pituitary-Adrenal Axis Function.” Also, if you are coming to ENDO 2023 in Chicago, be sure to join us for a live taping of the podcast in front of an audience, 10:30 a.m., Thursday, June 15, in the Professional Resources Center in the Expo Hall. We would love to meet you! For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753187</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753187/endocrine-feedback-loop/2026_04_21_17_16_04_f83952fc-44b0-4de2-9a0b-a26c0db94d4d.mp3" length="43878770" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/02485d7d03fa493b8b0fde505fbfbd24.mp3</guid>
      <itunes:duration>2731</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>4</itunes:season>
      <podcast:season>4</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 18 May 2023 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_2c6197626b027f90b5d806183f9009fe.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL036 - The Glycemic Gap in Hospitalized Patients With COVID]]></title>
      <itunes:title><![CDATA[EFL036 - The Glycemic Gap in Hospitalized Patients With COVID]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, as he discusses a recent article in The Journal of Clinical Endocrinology & Metabolism with Alyson Myers, MD, from Albert Einstein College of Medicine, and guest expert Cecilia Low Wang, MD, from University of Colorado. The article featured this month, by McDonnell et al, was published in the March 2023 issue of JCEM: “Glycemic Gap Predicts Mortality in a Large Multicenter Cohort Hospitalized With COVID-19.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753186</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753186/endocrine-feedback-loop/2026_04_21_17_16_12_5c31d8ae-6571-4da2-9a1e-45bf21043e2c.mp3" length="41851498" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/1cfda1d7b5d844fdbd7e88f86ae76d44.mp3</guid>
      <itunes:duration>2605</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 20 Apr 2023 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_29ac1ac2a451e1ec4b92a518657858a8.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL035 - Cryptorchidism's Impact on Markers of Reproduction]]></title>
      <itunes:title><![CDATA[EFL035 - Cryptorchidism's Impact on Markers of Reproduction]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, as he discusses a recent article in The Journal of Clinical Endocrinology & Metabolism with Marcela Vargas Trujillo, MD, from University of California, San Diego, and guest expert Alan Rogol, MD, PhD, from University of Virginia. The article featured this month, by Rodprasert et al, was published in the December 2022 issue of JCEM: “Reproductive Markers of Testicular Function and Size During Puberty in Boys With and Without a History of Cryptorchidism.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753185</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753185/endocrine-feedback-loop/2026_04_21_17_15_56_956ab8f3-7da1-4272-8ba9-dcfc7f2cd2c1.mp3" length="39501566" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/ab8552f5c61c4095a9bb2132db5beb61.mp3</guid>
      <itunes:duration>2458</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 16 Mar 2023 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_67fde68eabde1e563f915054c042d249.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL034 - Hypoparathyroidism Following Thyroidectomy]]></title>
      <itunes:title><![CDATA[EFL034 - Hypoparathyroidism Following Thyroidectomy]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center as he discusses a recent Journal of the Endocrine Society (JES) article with Alan Dalkin, MD, from University of Virginia and guest expert Suzanne Jan De Beur, MD, from The Johns Hopkins University School of Medicine. The article, by Martín-Román et al, was published in the January 2023 issue of JES: “Vitamin D Deficiency Reduces Postthyroidectomy Protracted Hypoparathyroidism Risk. Is Gland Preconditioning Possible?” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753184</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753184/endocrine-feedback-loop/2026_04_21_17_15_54_a659fcf1-4f93-4e70-abac-687f18ba16f2.mp3" length="37417251" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/5baaee8400384a8aaa2da2071845fae6.mp3</guid>
      <itunes:duration>2328</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 16 Feb 2023 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_45288257818fff87d9b346a94c1ff35c.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL033 - GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes]]></title>
      <itunes:title><![CDATA[EFL033 - GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center as he discusses an article in The Journal of Clinical Endocrinology & Metabolism with Ashok Balasubramanyam, MD, from Baylor College of Medicine and guest expert David Nathan, MD, from Harvard Medical School and Massachusetts General Hospital. The featured article, by Edwards et al, was first published online in October 2022 in JCEM: “Clinical and Safety Outcomes With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes: A Real-World Study.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753183</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753183/endocrine-feedback-loop/2026_04_21_17_16_00_51ccf8cc-50fe-489b-b2da-7a88b33a480e.mp3" length="51516411" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/a1f3cd87681f4ece9cfa9b5fcc462f4c.mp3</guid>
      <itunes:duration>3208</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 19 Jan 2023 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_82d9612912775aaba9376d0ccc3e54a4.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL032 - Inpatient Treatment of Osteoporotic Fractures]]></title>
      <itunes:title><![CDATA[EFL032 - Inpatient Treatment of Osteoporotic Fractures]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center as he discusses a recent article in The Journal of Clinical Endocrinology & Metabolism with Amal Shibli-Rahhal, MD, from University of Iowa Carver College of Medicine and Ann E. Kearns, MD, PhD, from Mayo Clinic. The article, by Fan et al, is from the January 2023 issue of JCEM: “Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753182</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753182/endocrine-feedback-loop/2026_04_21_17_15_53_55a00c9a-a02d-4ca1-becc-e9cb591445fa.mp3" length="50007740" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/c122b4f199af491ca811dd437a9b508b.mp3</guid>
      <itunes:duration>3114</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 15 Dec 2022 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_12dcb6bb4d84667f94c8ed282cf5cdd0.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL031 - Changes in Glucose Throughout the Menstrual Cycle in T1DM]]></title>
      <itunes:title><![CDATA[EFL031 - Changes in Glucose Throughout the Menstrual Cycle in T1DM]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center as he discusses a recent article in The Journal of Clinical Endocrinology & Metabolism with Steven D. Wittlin, MD, from the University of Rochester Medical Center and Mary Korytkowski, MD, from University of Pittsburgh. The article, by Tatulashvili et al, is from the October 2022 edition of JCEM: “Ambulatory Glucose Profile According to Different Phases of the Menstrual Cycle in Women Living With Type 1 Diabetes.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753181</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753181/endocrine-feedback-loop/2026_04_21_17_15_35_7b236c10-ab9d-4136-8148-89d40b2cb81b.mp3" length="40261631" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/47a0633cc2ff48558bb73c7d12e6bc44.mp3</guid>
      <itunes:duration>2506</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 17 Nov 2022 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_4faec17c2d109112d79dbe08b3fceb8f.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL030 - Medical Management of Cushing Disease]]></title>
      <itunes:title><![CDATA[EFL030 - Medical Management of Cushing Disease]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, as he discusses a recent article in The Journal of Clinical Endocrinology & Metabolism with Katie Guttenberg, MD, from University of Texas Health at Houston and Maria Fleseriu, MD, director of the NW Pituitary Center at Oregon Health & Science University. The article, by Gadelha et al, is from the July 2022 edition of JCEM: “Randomized Trial of Osilodrostat for the Treatment of Cushing Disease.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753179</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753179/endocrine-feedback-loop/2026_04_21_17_15_06_bcbba871-32d3-45ea-8843-1f731fee79d8.mp3" length="57206926" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/04225d9d8a71463b9e6c201d60e84eb9.mp3</guid>
      <itunes:duration>3567</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 20 Oct 2022 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_0d23457fd3e0d3bef47b78024feb451f.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL029 - Whom to Screen for Cushing Syndrome]]></title>
      <itunes:title><![CDATA[EFL029 - Whom to Screen for Cushing Syndrome]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center as he discusses a recent article in The Journal of Clinical Endocrinology & Metabolism with Salila Kurra, MD, from Columbia University Irving Medical Center and John Newell-Price, MD, from the University of Sheffield. The article is from the September 2022 edition of JCEM: “Whom Should We Screen for Cushing Syndrome? The Endocrine Society Practice Guideline Recommendations 2008 Revisited.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753178</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753178/endocrine-feedback-loop/2026_04_21_17_15_03_eb7fbe83-0ce1-42e3-a01e-106375776e34.mp3" length="41833142" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/cec0150c0ef64daf8212522347f0df07.mp3</guid>
      <itunes:duration>2606</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 22 Sep 2022 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_4c44a35e37e8d297a2ae0039feff4b4f.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL028 - Long Term Metabolic Effects of Weight Loss Surgery]]></title>
      <itunes:title><![CDATA[EFL028 - Long Term Metabolic Effects of Weight Loss Surgery]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt Unviersity Medical Center as he talks with Dan Bessesen, MD, from University of Colorado School of Medicine and Marc-Andre Cornier, MD, from the Medical University of South Carolina. The article is from the June 2022 edition of The Journal of Clinical Endocrinology & Metabolism: “Metabolic Slowing Vanished 5 Years After Sleeve Gastrectomy in Patients With Obesity and Prediabetes/Diabetes.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753177</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753177/endocrine-feedback-loop/2026_04_21_17_15_00_b478064c-6b15-4827-94fd-e177bf335910.mp3" length="47767897" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/db6babe22bfe478783cf9af287296a0a.mp3</guid>
      <itunes:duration>2977</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 25 Aug 2022 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_7f33d4820799985ca9638000f4c65030.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL027 - Androgen Therapy in Women with Hypopituitarism]]></title>
      <itunes:title><![CDATA[EFL027 - Androgen Therapy in Women with Hypopituitarism]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center as he discusses an article in The Journal of Clinical Endocrinology & Metabolism with Anna Goldman, MD, from Harvard Medical School and Margaret Wierman, MD, from University of Colorado School of Medicine. The article is from the August 2022 edition of JCEM: “DHEA on Sexual Function in Sheehan Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753176</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753176/endocrine-feedback-loop/2026_04_21_17_14_58_36ebc663-610a-4369-8b5b-8e3c4a3056b9.mp3" length="38455595" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/b00c2708411c4cbdb12b793c1fff5f19.mp3</guid>
      <itunes:duration>2395</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 28 Jul 2022 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_5125641bfe72ed98f9cd9ea2aab727f3.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL026 - RAI for Metastatic Thyroid Cancer]]></title>
      <itunes:title><![CDATA[EFL026 - RAI for Metastatic Thyroid Cancer]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt Unviersity Medical Center as he discusses a recent article in Journal of the Endocrine Society (JES) with Imali Sirisena, MD, from Temple University and Mike Tuttle, MD, from Memorial Sloan Kettering Cancer Center. The article is from the March 2022 edition of JES: “Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for 131I Administration.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753173</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753173/endocrine-feedback-loop/2026_04_21_17_15_13_5ab72ed0-8dea-4caf-a69a-b484764eb5ce.mp3" length="49450684" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/04267233d55b4f11b1297b42813d5379.mp3</guid>
      <itunes:duration>3079</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 16 Jun 2022 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_0b29e01810092ba90e418e561d0c8ab7.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL025 - Optimizing Steroid Replacement in CAH]]></title>
      <itunes:title><![CDATA[EFL025 - Optimizing Steroid Replacement in CAH]]></itunes:title>
      <description><![CDATA[Kicking off season 3 of Endocrine Feedback Loop, host Chase Hendrickson, MD, from Vanderbuilt University Medical Center discusses a recent article with two pediatric endocrinologists: Marcela Vargas Trujillo, MD, from the University of California, San Diego, and Rady Children’s Hospital and Selma Witchel, MD, from the University of Pittsburgh Medical Center Children’s Hospital of Pittsburgh. They discuss an article from The Journal of Clinical Endocrinology & Metabolism: “Optimizing the Timing of Highest Hydrocortisone Dose in Children and Adolescents with 21-Hydroxylase Deficiency.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753172</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753172/endocrine-feedback-loop/2026_04_21_17_15_22_4b7fe4aa-2170-40f3-91c5-ba0dd4d049fe.mp3" length="41632296" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/f53a26dcb73345b5bc56de0cc23730be.mp3</guid>
      <itunes:duration>2591</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 19 May 2022 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_5292f483701220f1332dc0af9661657d.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL024 - Monitoring Estradiol and DHT to Predict Outcomes in Male Hypogonadism]]></title>
      <itunes:title><![CDATA[EFL024 - Monitoring Estradiol and DHT to Predict Outcomes in Male Hypogonadism]]></itunes:title>
      <description><![CDATA[Join us for our 2-year anniversary episode! Host Chase Hendrickson, MD, from Vanderbilt University Medical Center; regular contributor Rich Comi, MD, from Dartmouth Hitchcock Medical Center; and male reproduction expert Mathis Grossman, MD, PhD, FRACP, from the University of Melbourne and Austin Health discuss an article from the January 2022 edition of The Journal of Clinical Endocrinology & Metabolism: “Relation of Testosterone, Dihydrotestosterone, and Estradiol with Changes in Outcomes Measures in the Testosterone Trials.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753171</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753171/endocrine-feedback-loop/2026_04_21_17_15_25_d7fa90fe-a207-49bf-a1d7-b13cdf28c413.mp3" length="48170557" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/fd070d51589549799c084e597ae51050.mp3</guid>
      <itunes:duration>2999</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 21 Apr 2022 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_8542125d10fff099388413bd8c106891.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL023 - CGM Metrics and Diabetes Complications]]></title>
      <itunes:title><![CDATA[EFL023 - CGM Metrics and Diabetes Complications]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt Unviersity Medical Center, as he talks with Alyson Myers, MD, from Montefiore/Albert Einstein, and Grazia Aleppo, MD, from the Feinberg School of Medicine at Northwestern University. The article featured is from the February 2022 edition of The Journal of Clinical Endocrinology & Metabolism: “Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults with T1D.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753170</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753170/endocrine-feedback-loop/2026_04_21_17_14_57_9d5c7ac3-77f0-4bfb-a5ac-7e3aca84f480.mp3" length="44788517" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/e3ed2e4ada7a43bbb82379204437f687.mp3</guid>
      <itunes:duration>2788</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 24 Mar 2022 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_f068c466bd739003c8f259dd2ee37c93.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL022 - Care Gaps in Primary Hyperparathyroidism]]></title>
      <itunes:title><![CDATA[EFL022 - Care Gaps in Primary Hyperparathyroidism]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt Unviersity Medical Center, as he discusses a recent article in The Journal of Clinical Endocrinology & Metabolism with Alan Dalkin, MD, from the University of Virginia and invited topical expert Cliff Rosen, MD, from the Northern New England Clinical and Translational Research Network. The article is from the December 2021 edition of JCEM: “Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-Based Assessment.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753169</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753169/endocrine-feedback-loop/2026_04_21_17_14_59_083ee50f-90cc-4fd9-bd16-c90feb7e6c6a.mp3" length="50286971" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/68750763c04048c093ed5d8584f08b48.mp3</guid>
      <itunes:duration>3132</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 24 Feb 2022 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_dbf3587325f07fb225ecead64bc97736.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL021 - Metabolic Effects of a Dual GIP and GLP-1 RA]]></title>
      <itunes:title><![CDATA[EFL021 - Metabolic Effects of a Dual GIP and GLP-1 RA]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt Unviersity Medical Center, as he discusses a recent article in The Journal of Clinical Endocrinology & Metabolism with Ashok Balasubramanyam, MD, from Baylor College of Medicine and invited topical expert Steven Bain, MD, from Swansea University. The article is from the February 2022 edition of JCEM: “Effects of Tirzepatide, a Dual GIP and GLP-1 RA, on Lipid and Metabolite Profiles in Subjects with T2D.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753168</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753168/endocrine-feedback-loop/2026_04_21_17_15_11_c898565a-f849-4ea3-9556-5bcacb11a5e7.mp3" length="46428129" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/244187762ec548fb8c1b5c517dd1dc56.mp3</guid>
      <itunes:duration>2891</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 27 Jan 2022 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_f0317eff3b850eb25ee18458b82b7301.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL020 - Zoledronate to Maintain BMD Gains After Denosumab]]></title>
      <itunes:title><![CDATA[EFL020 - Zoledronate to Maintain BMD Gains After Denosumab]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt Unviersity Medical Center, as he talks with Amal Shibli-Rahhal, MD, from University of Iowa and John Bilezikian, MD, PhD(hon), from Columbia University Medical Center. The article featured this month is from the May 2021 issue of The Journal of Clinical Endocrinology & Metabolism: “The Duration of Denosumab Treatment and the Efficacy of Zoledronate to Preserve Bone Mineral Density After its Discontinuation.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753167</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753167/endocrine-feedback-loop/2026_04_21_17_15_14_fde888bb-9a18-4f85-af87-49a408b4d372.mp3" length="48259686" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/a01024a9d383470eb99a8f1bdd3bb274.mp3</guid>
      <itunes:duration>3005</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 16 Dec 2021 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_06f9b919b8c188c8bb764ca744a08812.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL019 - Glycemic Variability and C-Peptide in T1DM]]></title>
      <itunes:title><![CDATA[EFL019 - Glycemic Variability and C-Peptide in T1DM]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt Unviersity Medical Center, as he discusses a recent article in Journal of the Endocrine Society (JES) selected by popular demand. He talks with Steve Wittlin, MD, from the University of Rochester School of Medicine and Dentistry and Adrian Vella, MD, FRCP(Edin), from the Mayo Clinic College of Medicine. The article featured this month was selected by fans and is from the October 2021 issue of JES: “Measurement of Peak C-Peptide at Diagnosis Informs Glycemic Control but not Hypoglycemia in Adults with Type 1 Diabetes.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753166</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753166/endocrine-feedback-loop/2026_04_21_17_14_40_b4b1a67d-dd05-45d6-964c-446d8d6f0cae.mp3" length="47367578" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/cc240f5ce01440fa95a007a632177614.mp3</guid>
      <itunes:duration>2960</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 24 Nov 2021 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_7d28d4276edf91735816c372ce46eb3a.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL018 - Trends and Disparities in DKA Admissions]]></title>
      <itunes:title><![CDATA[EFL018 - Trends and Disparities in DKA Admissions]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, along with Joshua Joseph, MD, MPH, FAHA, from The Ohio State University Wexner Medical Center, and Kasia Lipska, MD, from Yale University, as they discuss an article in the August 2021 issue of The Journal of Clinical Endocrinology & Metabolism: “National Trends in Pediatric Admissions for Diabetic Ketoacidosis, 2006–2016.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753165</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753165/endocrine-feedback-loop/2026_04_21_17_14_42_93a4daf7-0a8f-4757-a1ed-47604db2909e.mp3" length="51257543" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/51d6f7dbc425478a9c65edf1f7991f21.mp3</guid>
      <itunes:duration>3192</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 28 Oct 2021 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_541cdf2c7b37cdc734063fd70d6152a9.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL-B2P001 - Bench to Podcast: Interview with the Researcher]]></title>
      <itunes:title><![CDATA[EFL-B2P001 - Bench to Podcast: Interview with the Researcher]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center as he interviews Mary Elizabeth Patti, MD, from Harvard Medical School Joslin Diabetes Center, in a follow-up to “EFL015 - Hypoglycemia After Gastric Bypass.” Hear directly from one of the researchers who worked on “Glycemia Patterns are Distinct in Individuals with Post-Bariatric Hypoglycemia after Gastric Bypass (PBH-RYGB),” about how they selected their research topic, factors involved in developing their approach, and decisions they had to make as researchers. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753164</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753164/endocrine-feedback-loop/2026_04_21_17_14_23_5200b961-a712-477f-aefc-9f3934d88279.mp3" length="20317177" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/1e44f43556d8410cabd6671d34f97de4.mp3</guid>
      <itunes:duration>1260</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Tue, 19 Oct 2021 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_9243906c0d9023f070ff571ec3c81761.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL017 - Assessing Outcomes in Pituitary Surgery]]></title>
      <itunes:title><![CDATA[EFL017 - Assessing Outcomes in Pituitary Surgery]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, Katie Guttenberg, MD, from the McGovern Medical School at the University of Texas Science Center at Houston, and Ashley Grossman, MD, from the University of Oxford and Barts and the London School of Medicine, as they discuss an article from the September 2021 edition of The Journal of Clinical Endocrinology & Metabolism: “Outcome Squares Integrating Efficacy and Safety, as Applied to Functioning Pituitary Adenoma Surgery.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753163</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753163/endocrine-feedback-loop/2026_04_21_17_14_49_3aebdf43-56ae-4e8b-b4cc-1790ef340885.mp3" length="50071062" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/54cb08092ded46d79caa208488a3a1d0.mp3</guid>
      <itunes:duration>3118</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 23 Sep 2021 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_86ce72858a759007e99f3ccdff514970.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL016 - Imaging in Primary Aldosteronism]]></title>
      <itunes:title><![CDATA[EFL016 - Imaging in Primary Aldosteronism]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center; Salila Kurra, MD, from Columbia University Irving Medical Center; and Adina Turcu, MD, MS, from the University of Michigan. They discuss an article in the July 2021 issue of The Journal of Clinical Endocrinology & Metabolism: “Identification of Surgically Curable Primary Aldosteronism by Imaging in a Large, Multiethnic Iternational Study.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753162</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753162/endocrine-feedback-loop/2026_04_21_17_14_35_1f3b2546-f775-4964-96a5-3239ce42c46e.mp3" length="47851152" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/bd21b541808f43eb9dd0b1d357161ca4.mp3</guid>
      <itunes:duration>2980</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 26 Aug 2021 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_9eb5d9efa184e0b6dc6b516d20e8c07d.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL015 - Hypoglycemia After Gastric Bypass]]></title>
      <itunes:title><![CDATA[EFL015 - Hypoglycemia After Gastric Bypass]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, along with Marc-Andre Cornier, MD, from University of Colorado School of Medicine and Marzieh Salehi, MD, MS, FACP, from the Bartter Research Unit at the South Texas Veteran Health Care System, as they discuss an article from the May 2021 edition of The Journal of Clinical Endocrinology & Metabolism: “Glycemia Patterns are Distinct in Individuals with Post-Bariatric Hypoglycemia after Gastric Bypass (PBH-RYGB).” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753161</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753161/endocrine-feedback-loop/2026_04_21_17_14_52_64bafd7d-85e8-4529-8fc3-661a62a38ea3.mp3" length="61527785" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/614c4a6d7e9049eb868ffbaa4ef170f7.mp3</guid>
      <itunes:duration>3833</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 29 Jul 2021 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_7e4a4b7282cded35c87c9e480dee3b08.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL014 - Erythrocytosis Risk in Trans Men]]></title>
      <itunes:title><![CDATA[EFL014 - Erythrocytosis Risk in Trans Men]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, for the June 2021 edition of Endocrine Feedback Loop. This episode features Anna Goldman, MD, from Brigham and Women’s Hospital and Vin Tangpricha, MD, PhD, from Emory University School of Medicine, expert in the endocrine care of persons with gender identity disorders and a member of the Endocrine Society Transgender Research & Medicine Special Interest Group. They discuss an article from the May 2021 edition of Journal of the Endocrine Society: “Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753158</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753158/endocrine-feedback-loop/2026_04_21_17_13_36_4878f57a-b356-4b18-a17d-ddf5a526bf5b.mp3" length="42905075" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/e0db7db643a647c68773acb1bf598074.mp3</guid>
      <itunes:duration>2671</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 17 Jun 2021 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_bb8b41bdea83384c640b0eeb2c9e5624.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL013 - Complications of Cushing Syndrome]]></title>
      <itunes:title><![CDATA[EFL013 - Complications of Cushing Syndrome]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, as he talks with Imali Sirisena, MD, from Temple University Hospital and Dr. Shlomo Melmed, MB, ChB, FRCP, MACP, from Cedars-Sinai Medical Center and leading expert in treating Cushing syndrome. They focus on an article from the May 2021 edition of The Journal of Clinical Endocrinology & Metabolism: “Acute and Life-Threatening Complications in Cushing Syndrome: Prevalence, Predictors, and Mortality.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753157</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753157/endocrine-feedback-loop/2026_04_21_17_13_56_ccee982f-524a-44b8-96f9-323e2444030a.mp3" length="54099404" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/72562322438b48fd9f8d023fc742aa73.mp3</guid>
      <itunes:duration>3370</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 20 May 2021 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_251fec1afd0b212db33ba3197fc3c2bb.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL012 - A1c Trajectories During Adolescent-to-Adult Transition]]></title>
      <itunes:title><![CDATA[EFL012 - A1c Trajectories During Adolescent-to-Adult Transition]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, along with expert educator Ashok Balasubramanyam, MD, from Baylor College of Medicine and invited topical expert Irl Hirsch, MD, MACP, from the University of Washington, as they discuss a recent article from The Journal of Clinical Endocrinology & Metabolism: “Improvement in A1c Levels in Early Adulthood in T1D Exchange: Impact of Racial, Socioeconomic, and Clinical Factors.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753156</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753156/endocrine-feedback-loop/2026_04_21_17_13_49_efed9b17-28bb-46dc-88e8-3f899c7f6029.mp3" length="56514882" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/c27f973f8c5b4b35810a0a6c6c27f510.mp3</guid>
      <itunes:duration>3520</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 22 Apr 2021 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_291be7154c7bab99d9587e22e0bfd873.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL011 - Stages of Cystic Fibrosis-Related Diabetes]]></title>
      <itunes:title><![CDATA[EFL011 - Stages of Cystic Fibrosis-Related Diabetes]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, as he talks with Rich Comi, MD, from Dartmouth Hitchcock Medical Center and Kim Donaghue, MBBS, PhD, FRACP, from the University of Sydney and the Children’s Hospital at Westmead. They discuss an article from The Journal of Clinical Endocrinology & Metabolism: “Glucose Tolerance Stages in Cystic Fibrosis Are Identified by a Unique Pattern of Defects of Beta-Cell Function.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753155</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753155/endocrine-feedback-loop/2026_04_21_17_13_16_aca45cc2-a797-4fbf-99c9-793c1b5a6113.mp3" length="46995613" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/b8658d33e4ab4eeb9528f57bfb10a11d.mp3</guid>
      <itunes:duration>2926</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Fri, 26 Mar 2021 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_220bc13e26bc19d8ddf816789725218a.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL010 - New Therapy for Adrenal Insufficiency]]></title>
      <itunes:title><![CDATA[EFL010 - New Therapy for Adrenal Insufficiency]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, as he talks with Salila Kurra, MD, from Columbia University Irving Medical Center and Andrea Utz, MD, PhD, also from Vanderbilt University. They discuss an article from The Journal of Clinical Endocrinology & Metabolism: “Improved Urinary Cortisol Metabolome in Addison Disease: A Prospective Trial of Dual-Release Hydrocortisone.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753152</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753152/endocrine-feedback-loop/2026_04_21_17_12_23_0cfa7317-58eb-49af-b58d-e5d1dd99a3e0.mp3" length="54390467" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/c1593497cffb4ef5a6463ef3164c230f.mp3</guid>
      <itunes:duration>3388</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 18 Mar 2021 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_fb1357c549584bee498c1b62c9ce2176.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL009 - Imaging in Primary Hyperparathyroidism]]></title>
      <itunes:title><![CDATA[EFL009 - Imaging in Primary Hyperparathyroidism]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, along with Alan Dalkin, MD, from the University of Virginia and Dolores Shoback, MD, from the San Francisco Veterans Affairs Medical Center and the University of California, San Francisco. They discuss an article in The Journal of Clinical Endocrinology & Metabolism: “Use of Preoperative Imaging in Primary Hyperparathyroidism.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753151</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753151/endocrine-feedback-loop/2026_04_21_17_12_19_b63130e2-4359-4d3a-923a-963672937eff.mp3" length="56623790" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/1b938a3491af48f5821414a3e2f64dab.mp3</guid>
      <itunes:duration>3527</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 28 Jan 2021 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_597960b82cd7659b5b5023685ab87dec.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL008 - Alternatives to Surgery for Thyroid Cancer]]></title>
      <itunes:title><![CDATA[EFL008 - Alternatives to Surgery for Thyroid Cancer]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, as he talks with Amal Shibli-Rahhal, MD, from University of Iowa and Bryan Haugen, MD, from University of Colorado School of Medicine. They discuss a recent Journal of the Endocrine Society article: “Long-Term Results of Treating with Ethanol Ablation 15 Adult Patients with cT1aNo Papillary Thyroid Microcarcinoma.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753150</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753150/endocrine-feedback-loop/2026_04_21_17_12_19_be87f66d-c7e5-4991-b697-cda3868d29bf.mp3" length="48055098" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/e2f98b6dc6c94cad948a2e205d7f0d74.mp3</guid>
      <itunes:duration>2992</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 17 Dec 2020 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_359d7b31978a6d93f79e6bbc87312768.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL007 - Inpatient Hyponatremia]]></title>
      <itunes:title><![CDATA[EFL007 - Inpatient Hyponatremia]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, along with Marc-Andre Cornier, MD, from University of Colorado School of Medicine and Joseph Verbalis, MD, expert in hyponatremia from Georgetown University, as they discuss an article in The Journal of Clinical Endocrinology & Metabolism: “Risk of Adverse Clinical Outcomes in Hyponatremic Adult Patients Hospitalized for Acute Medical Conditions: A Population-Based Cohort Study.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753147</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753147/endocrine-feedback-loop/2026_04_21_17_11_44_e7080006-a4aa-4284-bdea-1f32a8511db1.mp3" length="55748947" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/f74805837f75425ab1b36cb894abd528.mp3</guid>
      <itunes:duration>3473</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 19 Nov 2020 05:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_2c770d301cf43d4804dcdc69ce1ce69c.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL006 - Hybrid Closed Loops and Preventing Hypoglycemia]]></title>
      <itunes:title><![CDATA[EFL006 - Hybrid Closed Loops and Preventing Hypoglycemia]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, as he talks with Steve Wittlin, MD, professor of medicine at the University of Rochester School of Medicine and Dentistry and Director of Diabetes Services/Endocrine-Metabolism Division at the University of Rochester Medical Center, and Anne Peters, MD, professor of clinical medicine at the Keck School of Medicine, University of Southern California, and director of the USC Clinical Diabetes Program. They discuss an article in The Journal of Clinical Endocrinology & Metabolism: “Artificial Pancreas with Carbohydrate Suggestion Performance for Unannounced and Announced Exercise in Type 1 Diabetes.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753146</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753146/endocrine-feedback-loop/2026_04_21_17_11_37_2d7b429b-7ea3-4bd5-a31a-cfdf79a83734.mp3" length="53797921" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/b57be328f75d44038d6f0a150280a88c.mp3</guid>
      <itunes:duration>3351</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 22 Oct 2020 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_fbd7119d832a43b0e9c73e975d42539d.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL005 - Bariatric Surgery in PCOS]]></title>
      <itunes:title><![CDATA[EFL005 - Bariatric Surgery in PCOS]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, along with Anna Goldman, MD, associate program director of fellowship at Brigham and Women’s Hospital, and Andrea Dunaif, MD, an expert in women’s health and endocrinology in the Mount Sinai Health System, as they discuss a recent article in The Journal of Clinical Endocrinology & Metabolism: “Fertility and Pregnancy Outcomes in Women with Polycystic Ovary Syndrome Following Bariatric Surgery.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753145</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753145/endocrine-feedback-loop/2026_04_21_17_11_19_83db7ae9-a249-4473-b6c3-2b471b4b33d8.mp3" length="46215553" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/e1652b48a9054df9ad26733b98cc224a.mp3</guid>
      <itunes:duration>2877</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 24 Sep 2020 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_01b56ca6c80b1e5481c656b28afedcea.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL004 - Assessing Delayed Puberty]]></title>
      <itunes:title><![CDATA[EFL004 - Assessing Delayed Puberty]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, along with Marcela Vargas Trujillo, MD, expert educator and provider at the University of California, San Diego, and Rady Children’s Hospital, and Fernando Cassorla, MD, an expert in puberty and Chief of Pediatric Endocrinology at the University of Chile. They discuss a recent article in The Journal of Clinical Endocrinology & Metabolism: “Using Kisspeptin to Predict Pubertal Outcomes for Youth with Pubertal Delay.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753144</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753144/endocrine-feedback-loop/2026_04_21_17_11_39_4c866bc7-6754-44d6-a93a-2be97b714797.mp3" length="58442331" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/5593b806cfd842cf9a2c1f6a2b43d62e.mp3</guid>
      <itunes:duration>3641</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 27 Aug 2020 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_d33a7b91a9725c1b24861eb26767e41d.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL003 - Hydrocortisone Stress Dosing]]></title>
      <itunes:title><![CDATA[EFL003 - Hydrocortisone Stress Dosing]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, for a discussion with Katie Guttenberg, MD, program director and assistant professor at McGovern Medical School at the University of Texas Health Science Center at Houston, and Lynnette Nieman, MD, senior investigator at the National Institutes of Health and head of the Endocrine Consult Service at the NIH Clinical Center specializing in cortisol disorders. This episode explores a recently published article from the July 2020 print edition of The Journal of Clinical Endocrinology & Metabolism: “Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753143</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753143/endocrine-feedback-loop/2026_04_21_17_12_00_bb3dd7d4-8616-47c7-9613-9fbd3435f2f5.mp3" length="56472648" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/a8cdc07aab564cddad9c1d1af31919fe.mp3</guid>
      <itunes:duration>3518</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 16 Jul 2020 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_ad1571e9dd88cc6525c9a7d4f059e09a.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL002 - Recovery from Androgen Abuse]]></title>
      <itunes:title><![CDATA[EFL002 - Recovery from Androgen Abuse]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, for the June 2020 edition of Endocrine Feedback Loop. This episode features Dr. Imali Sirisena, MD, Associate Program Director at Temple University, and Brad Anawalt, MD, Chief Medical Officer from University of Washington Medical Center and a leading expert in hypogonadism and androgen abuse. This month ’ s discussion will focus on an article from the June 2020 print edition of The Journal of Clinical Endocrinology & Metabolism: “Rate and Extent of Recovery from Reproductive and Cardiac Dysfunction Due to Androgen Abuse in Men.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753141</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753141/endocrine-feedback-loop/2026_04_21_17_10_49_dc7a7ec5-94f0-4fd4-89a6-575d3c4cd89a.mp3" length="58207743" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/8bd57a192f9549f2a57e4c9603488e65.mp3</guid>
      <itunes:duration>3626</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 18 Jun 2020 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_e86d525b045ad7e16bcaf55172c89504.jpg"/>
    </item>
    <item>
      <title><![CDATA[EFL001 - Confirmatory Testing in Primary Aldosteronism]]></title>
      <itunes:title><![CDATA[EFL001 - Confirmatory Testing in Primary Aldosteronism]]></itunes:title>
      <description><![CDATA[Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, for the launch of Endocrine Feedback Loop. This episode features Richard Comi, MD, expert educator from Dartmouth Hitchcock Medical Center, and William Young, MD, leading expert in primary aldosteronism from Mayo Clinic (Rochester), discussing “Role of Aldosterone and Potassium Levels in Sparing ConfirmatoryTests in Primary Aldosteronism,” from the April 2020 print edition of The Journal of Clinical Endocrinology & Metabolism. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series]]></description>
      <link>https://rss.com/podcasts/endocrine-feedback-loop/2753140</link>
      <enclosure url="https://content.rss.com/episodes/383117/2753140/endocrine-feedback-loop/2026_04_21_17_09_30_eb702827-3769-4900-99e1-23f86205c097.mp3" length="51196793" type="audio/mpeg"/>
      <guid isPermaLink="false">https://www.endocrine.org/-/media/25cc4275449740808c41ca87e647f228.mp3</guid>
      <itunes:duration>3188</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 20 May 2020 04:00:00 GMT</pubDate>
      <itunes:image href="https://media.rss.com/endocrine-feedback-loop/cover_0092cc38e722b770a45a219d960c1de7.jpg"/>
    </item>
  </channel>
</rss>